డొక్కలం తరువాత చైనా నుంచి ఔషధ రంగ దిగుమతులు 28 % పెరిగాయి||Drug imports(China) up 28% since Doklam||
India's aspiration to reduce its dependency on China in the pharmaceutical sector has remained on paper so far, show figures. During the 2017 Doklam standoff, Indian manufacturers of active pharmaceutical ingredients (APIs) had called for policies to reduce imports of the key raw material from China and increase their local production.
The country’s imports of pharmaceutical products from China, however, rose to ₹1,150 crore in 2019-20 from ₹947 crore in 2015-16, a cumulative growth of 28%, according to data from the commerce ministry.Imports of miscellaneous pharma products jumped 58% to ₹276 crore in this period. Including pharma ingredients, chemicals and key starting materials that get reported in various other categories, India’s imports from China are estimated to be about $2 billion (₹ 15,250 crore) a year.
Drug makers say that the low cost of importing these items, along with slow movement on the policy front for encouraging the domestic bulk drug industry, led companies to continue relying on Chinese imports.
About SocialNewsXYZ
An Indo-American News website. It covers Gossips, Politics, Movies, Technolgy, and Sports News and Photo Galleries and Live Coverage of Events via Youtube. The website is established in 2015 and is owned by AGK FIRE INC.
డొక్కలం తరువాత చైనా నుంచి ఔషధ రంగ దిగుమతులు 28 % పెరిగాయి||Drug imports(China) up 28% since Doklam|| India's aspiration to reduce its dependency on China in the pharmaceutical sector has remained on paper so far, show figures. During the 2017 Doklam standoff, Indian manufacturers of active pharmaceutical ingredients (APIs) had called for policies to reduce imports of the key raw material from China and increase their local production. The country’s imports of pharmaceutical products from China, however, rose to ₹1,150 crore in 2019-20 from ₹947 crore in 2015-16, a cumulative growth of 28%, according to data from the commerce ministry.Imports of miscellaneous pharma products jumped 58% to ₹276 crore in this period. Including pharma ingredients, chemicals and key starting materials that get reported in various other categories, India’s imports from China are estimated to be about $2 billion (₹ 15,250 crore) a year. Drug makers say that the low cost of importing these items, along with slow movement on the policy front for encouraging the domestic bulk drug industry, led companies to continue relying on Chinese imports.